Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid

Bipolar Disorders

Volumn 18, Issue 1, 2016, Pages 63-70

  Forlenza, Orestes V ^a   Aprahamian, Ivan ^a,b   Radanovic, Márcia ^a   Talib, Leda L ^a   Camargo, Marina Z A ^a   Stella, Florindo ^a,c   Machado Vieira, Rodrigo ^a,d   Gattaz, Wagner F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Dermatology   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alzheimer's disease; Biomarkers; Bipolar disorder; Cerebrospinal fluid; Dementia; Mild cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; PHOSPHOPROTEIN;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDUCATIONAL STATUS; FEMALE; HUMAN; LATE LIFE DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; TAU PROTEINS;

EID: 84958653577     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12360     Document Type: Article

References (49)

1. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic subjects with bipolar disorder. J Affect Disord 2006; 93: 105-115.
2. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar subjects and their first-degree relatives. Psychol Med 2008; 38: 771-785.
3. Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry 2007; 190: 359-360.
4. Samamé C, Martino DJ, Strejilevich SA. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord 2013; 15: 633-644.
5. Aprahamian I, Nunes PV, Forlenza OV. Cognitive impairment and dementia in late-life bipolar disorder. Curr Opin Psychiatry 2013; 26: 120-123.
6. Forlenza OV, Aprahamian I. Cognitive impairment and dementia in bipolar disorder. Front Biosci 2013; 5: 258-265.
7. Zarate CA Jr, Tohen M, Land M, Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatr Q 2000; 71: 309-329.
8. Sanchez-Moreno J, Martinez-Aran A, Colom F et al. Neurocognitive dysfunctions in euthymic bipolar subjects with and without prior history of alcohol use. J Clin Psychiatry 2009; 70: 1120-1127.
9. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MMB. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 2008; 70: 1258-1264.
10. Gualtieri CT, Johnson LG. Age-related cognitive decline in subjects with mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 962-967.
11. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in subjects with depressive disorder and in subjects with bipolar disorder? J Neurol Neurosurg Psychiatry 2004; 75: 1662-1666.
12. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
13. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; 434: 17-26.
14. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65: 1017-1032.
15. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 2008; 10: 1-37.
16. Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M. Manic episodes are associated with grey matter volume reduction: a voxel-based morphometry brain analysis. Acta Psychiatr Scand 2010; 122: 507-515.
17. da Silva J, Gonçalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry 2013; 202: 177-186.
18. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010; 12: 87-94.
19. Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 2007; 22: 733-737.
20. Dunner DL. Safety and tolerability of emerging pharmacological treatments for bipolar disorder. Bipolar Disord 2005; 7: 307-325.
21. Nivoli AM, Murru A, Pacchiarotti I et al. Bipolar disorder in the elderly: a cohort study comparing older and younger patients. Acta Psychiatr Scand 2014; 130: 364-373.
22. Gildengers A, Tatsuoka C, Bialko C et al. Correlates of disability in depressed older adults with bipolar disorder. Cut Edge Psychiatry Pract 2013; 2013: 332-338.
23. Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 2012; 25: 20-25.
24. Tsai SY, Kuo CJ, Chung KH, Huang YL, Lee HC, Chen CC. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 1004-1011.
25. Manji HK, Quiroz JA, Payne JL et al. The underlying neurobiology of bipolar disorder. World Psychiatry 2003; 2: 136-146.
26. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010; 6: 131-144.
27. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 288-234.
28. Kita Y, Baba H, Maeshima H, Nakano Y, Suzuki T, Arai H. Serum amyloid beta protein in young and elderly depression: a pilot study. Psychogeriatrics 2009; 9: 180-185.
29. Qiu WQ, Sun X, Selkoe DJ et al. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly. Int J Geriatr Psychiatry 2007; 22: 536-542.
30. Sun X, Mwamburi DM, Bungay K et al. Depression, antidepressants, and plasma amyloid beta (beta) peptides in those elderly who do not have cardiovascular disease. Biol Psychiatry 2007; 62: 1413-1417.
31. Reis T, Brandão CO, Freire Coutinho ES, Engelhardt E, Laks J. Cerebrospinal fluid biomarkers in Alzheimer's disease and geriatric depression: preliminary findings from Brazil. CNS Neurosci Ther 2012; 18: 524-529.
32. Piccinni A, Origlia N, Veltri A et al. Plasma β-amyloid peptides levels: a pilot study in bipolar depressed subjects. J Affect Disord 2012; 138: 160-164.
33. Jakobsson J, Zetterberg H, Blennow K, Johan EC, Johansson AG, Landén M. Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of subjects with bipolar disorder. Neuropsychopharmacology 2013; 38: 664-672.
34. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Arlington, TX: APA, 1994.
35. Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry 2013; 28: 34-40.
36. Flaks MK, Forlenza OV, Pereira FS, Viola LF, Yassuda MS. Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adults. Arch Clin Neuropsychol 2009; 24: 301-306.
37. Yassuda MS, Flaks MK, Viola LF et al. Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil. Int Psychogeriatr 2010; 22: 1003-1011.
38. Pereira FS, Oliveira AM, Diniz BS, Forlenza OV, Yassuda MS. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Arch Clin Neuropsychol 2010; 25: 335-343.
39. Diniz BS, Nunes PV, Yassuda MS et al. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr 2008; 30: 316-321.
40. Forlenza OV, Diniz BS, Talib LL et al. Clinical and biological predictors of Alzheimer's disease in subjects with amnestic mild cognitive impairment. Rev Bras Psiquiatr 2010; 32: 216-222.
41. Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
42. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
43. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer disease: Report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Service task force on Alzheimer disease. Neurology 1984; 34: 939-944.
44. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
45. Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med 2011; 364: 2227-34.
46. Forlenza OV, Diniz BS, Nunes PV, Memória CM, Yassuda MS, Gattaz WF. Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr 2009; 21: 1088-1095.
47. Radanovic M, Nunes PV, Gattaz WF, Forlenza OV. Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int Psychogeriatr 2008; 20: 687-696.
48. Aprahamian I, Ladeira RB, Diniz BS, Forlenza OV, Nunes PV. Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening tests. Am J Geriatr Psychiatry 2014; 22: 389-397.
49. Rolstad S, Jakobsson J, Sellgren C et al. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls. PLoS ONE 2015; 10: e0127100.